Trial
NCT01637545
Evaluation of Safety and Efficacy of Nasea(R)/Ramosetron Inj. in Patients Undergoing Facial Bone Fracture Operations
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Seoul National University Hospital
Collaborators
—
Condition
Facial Bones Fracture
Intervention
Ramosetron
Why stopped
Principal Investigator is away on business
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-08